AGNG:NSD-Global X Aging Population ETF (USD)

ETF | Others |

Last Closing

USD 32.8328

Change

+0.01 (+0.04)%

Market Cap

USD 0.06B

Volume

3.42K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

+0.53 (+0.26%)

USD 33.55B
QQQM Invesco NASDAQ 100 ETF

+0.53 (+0.26%)

USD 33.55B
ACWI iShares MSCI ACWI ETF

-0.01 (-0.01%)

USD 19.10B
ACWI iShares MSCI ACWI ETF

-0.01 (-0.01%)

USD 19.10B
IBIT iShares Bitcoin Trust

-1.26 (-3.37%)

USD 17.74B
IBIT iShares Bitcoin Trust

-1.26 (-3.37%)

USD 17.74B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.13 (+0.24%)

USD 16.68B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.13 (+0.24%)

USD 16.68B
CGABL The Carlyle Group Inc. 4.625% ..

-0.37 (-1.86%)

USD 16.14B
CGABL The Carlyle Group Inc. 4.625% ..

-0.37 (-1.86%)

USD 16.14B

ETFs Containing AGNG

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.45% 79% B- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.45% 76% C+ 72% C
Trailing 12 Months  
Capital Gain 27.51% 74% C 71% C-
Dividend Return 0.47% 7% C- 5% F
Total Return 27.98% 74% C 70% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.58% N/A N/A 45% F
Dividend Return 1.06% N/A N/A 41% F
Total Return 0.47% N/A N/A 13% F
Risk Return Profile  
Volatility (Standard Deviation) 9.47% N/A N/A 88% B+
Risk Adjusted Return 11.14% N/A N/A 48% F
Market Capitalization 0.06B 55% F 31% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike